A specialized clinical seminar focusing on supportive care in oncology was held on January 25, 2026, at the Awat Center for Radiation Oncology in Erbil, in collaboration with XenoFarma and Erbozeta. The event was designed specifically for radiation oncologists, with the aim of improving quality of life and long-term outcomes for cancer survivors.
The seminar featured a dual-topic scientific agenda addressing two clinically relevant post-radiation challenges:
Targeted Management of Radiation Proctitis with Dual-Phase Therapy
This session explored innovative therapeutic protocols for managing radiation-induced proctitis, emphasizing targeted, phase-based treatment strategies aimed at reducing tissue inflammation, promoting healing, and minimizing long-term complications.
Recent Guideline Updates on the Non-Antibiotic Management of Recurrent Cystitis
The second session reviewed contemporary guideline updates focusing on non-antibiotic approaches to recurrent cystitis, particularly in the context of post-radiation complications. Emphasis was placed on antibiotic stewardship, recurrence prevention, and supportive strategies aligned with modern clinical recommendations.
By integrating updated guidelines and targeted therapeutic approaches into daily practice, the seminar highlighted the evolving role of evidence-based supportive care in radiation oncology. The interactive format encouraged clinical discussion and knowledge exchange among specialists.
XenoFarma continues to support high-level scientific education and multidisciplinary collaboration, reinforcing its commitment to advancing oncology supportive care through innovative, guideline-driven solutions.
Event Date: January 25, 2026
Start Time: 12:00 PM
Venue: Awat Center for Radiation Oncology
City: Erbil, Iraq
